Peter Attia· MD
I would say that if a young person is in a situation where perhaps they can't afford bentidoic acid next Lizette PCS going down Inhibitors because to be clear those drugs are expensive at this time and statins are not
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I would say that if a young person is in a situation where perhaps they can't afford bentidoic acid next Lizette PCS going down Inhibitors because to be clear those drugs are expensive at this time and statins are not
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I would say that if a young person is in a situation where perhaps they can't afford bidic acid NEX lasette PCS Inhibitors because to be clear those drugs are expensive at this time and statins are not yeah your alternative might be well I'm going to be on a Statin um at least go through the trouble of trying to find the right one that produces the fewest side effects we think that probably pitavastatin or lielo uh resua stat and her Crestor probably the best places to go